The University of Arizona Wordmark Line Logo White The University of Arizona Health Sciences | Home Casting a Green Light On Fibromyalgia, The Invisible Disease Casting a green light on fibromyalgia, the invisible disease People with fibromyalgia may have another treatment option available soon thanks to continuing research at the Comprehensive Center for Pain and Addiction Researchers at the University of Arizona Health Sciences are exploring green light therapy as a potential treatment option for people with fibromyalgia, a puzzling disease that affects approximately 10 million people — mostly women…
Read MoreTag: Fibro
New Wayne State research findings offers hope to people with fibromyalgia
novel psychological therapy that encourages addressing emotional experiences related to trauma, conflict and relationship problems has been found helpful for people with the chronic pain condition fibromyalgia. A research team led by Mark A. Lumley, Ph.D., distinguished professor of psychology in the College of Liberal Arts and Sciences at Wayne State University, in collaboration with a team from the University of Michigan Medical Center led by David A. Williams, Ph.D., professor of anesthesiology, has released the results of its research in the prestigious journal, PAIN. In the randomized clinical…
Read MoreAtopic Dermatitis Significantly Raises Risk of Fibromyalgia, New Study Shows
Patients with atopic dermatitis (AD) face a markedly higher likelihood of developing fibromyalgia, a large Taiwanese cohort study published in the Indian Journal of Dermatology, Venereology and Leprology has suggested. The nationwide analysis revealed that individuals with AD had more than a sevenfold greater risk of fibromyalgia compared with people without the skin condition. The risk was even more pronounced in those with moderate-to-severe AD and among younger patients, highlighting the need for early pain assessment and monitoring in this population. The research was led by Dr. Chien-Peng Huang from…
Read MoreDuloxetine, milnacipran and pregabalin improve fibromyalgia pain for one in 10 patients
Duloxetine, milnacipran and pregabalin can yield significant pain relief over at least 12 weeks for approximately one out of 10 adults with fibromyalgia, according to an analysis of Cochrane reviews published in Rheumatology. “Pharmacological interventions are recommended as part of a multidisciplinary approach combined with physical and/or cognitive interventions for severe forms of [fibromyalgia syndrome],” Andrew Moore, formerly a consultant with the National Health Service in the United Kingdom, and colleagues wrote. “Treatment is often by antidepressants (typically duloxetine and amitriptyline) or antiepileptics (typically gabapentin or pregabalin). Substantial (worthwhile) pain…
Read MoreStudy: Cannabis Treatment Provides Sustained Relief for Patients With Fibromyalgia
London, United Kingdom: Patients with fibromyalgia (FM) report sustained improvements in their health-related quality of life following the use of medical cannabis preparations, according to observational data published in the journal Clinical Rheumatology. British investigators assessed the adjunctive use of cannabis-based medicinal products (CBMPs) in a cohort of 497 FM patients enrolled in the UK Medical Cannabis Registry. (British health care providers may prescribe cannabis-based medicinal products to patients unresponsive to conventional medications.) Patients’ outcomes were assessed at baseline and at 1, 3, 6, 12, and 18 months. Study participants…
Read MoreHow to Get Better Sleep When You Have Fibromyalgia
With a few sleep hygiene tweaks, you can ease fibromyalgia pain and get more shut-eye. How to Get Better Sleep When You Have Fibromyalgi Medically Reviewed bySian Yik Lim, MD A bad night’s sleep can leave anyone feeling drained and cranky. But when you have fibromyalgia, the impact can be much worse. Fibromyalgia can disrupt sleep patterns, leading to intensified pain. “Sleep problems are often interconnected with chronic pain, which means poor sleep can exacerbate fatigue and increase pain sensitivity,” says Shailendra Singh, MD, a board-certified rheumatologist at Unity…
Read MoreDaily briefing: Fibromyalgia eases after doses of gut microbes
In an unprecedented effort, a coalition of more than 50 research teams has double-checked a swathe of Brazilian biomedical studies — and was able to replicate less than half. That rate is in keeping with that found by other large-scale attempts to reproduce scientific findings. But the latest work assessed publications “based on methods, rather than research area, perceived importance or citation counts”, says metascience researcher Mariana Boechat de Abreu, one of the project coordinators. “We now have the material to start making changes from within” to improve the status…
Read MoreHow to Come to Terms With a Fibromyalgia Diagnosis
Connections: What I Wish I Knew About Fibromyalgia How to Come to Terms With a Fibromyalgia Diagnosis A Fibromyalgia Diagnosis Doesn’t Have to Define You Naomi thought a fibromyalgia diagnosis would bring relief, but it only brought more questions. Lynne shares how to accept a diagnosis. MORE VIDEOS IN Fibromyalgia A Fibromyalgia Diagnosis Doesn’t Have to Define You NOW PLAYING A Fibromyalgia Diagnosis Doesn’t Have to Define You Self-Care Can Make Fibromyalgia More Manageable NOW PLAYING Self-Care Can Make Fibromyalgia More Manageable Fibromyalgia Is Misunderstood, But It’s Real NOW…
Read More‘I want to live my life’: Fibromyalgia sufferers being failed by NHS
People suffering from the chronic pain condition fibromyalgia are being failed by the NHS, according to new research which found patients were waiting years for diagnosis, undergoing unnecessary tests and being prescribed harmful drugs. Researchers at Aberdeen University said some doctors were even refusing to refer patients and dismissing them as “lazy”. The senior consultant who led the UK-wide research is now calling on the NHS to overhaul its care of fibromyalgia patients. The Scottish government said it would continue to work closely with the NHS to improve how…
Read MoreChildren and adolescents affected by juvenile fibromyalgia are more sensitive to non-painful sensory stimuli
The findings provide new insights into the brain mechanisms underlying juvenile fibromyalgia, a chronic pain disorder that affects between 2% and 6% of children and adolescents. By combining detailed behavioural assessments with advanced brain imaging, the authors have defined patient subtypes that could explain why this disease is more disabling in some cases than in others. The study opens up new avenues for improving diagnosis and developing more personalized therapeutic strategies to address a paediatric disease that is still difficult to characterize and manage. Juvenile fibromyalgia: how does the…
Read More